AI Summary

Researchers at the Germans Trias i Pujol Research Institute and the Blood and Tissue Bank have created and validated a semiautomated platform that produces extracellular vesicles meeting pharmaceutical quality standards, a crucial advance toward clinical use. Extracellular vesicles are tiny cell‑derived particles that transport molecules capable of influencing biological processes such as inflammation. Vesicles sourced from mesenchymal stromal cells are gaining attention for their regenerative‑medicine potential. The new platform addresses the need for standardized, reproducible manufacturing processes required to move these therapies from the lab to patients.

AI summaries can be wrong sometimes—always verify important details using the source article.